Real-world data of six patients with atypical hemolytic uremic syndrome switched to ravulizumab.

ABSTRACT:

SUBMITTER: Ehren R 

PROVIDER: S-EPMC8445866 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature